These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 3322119

  • 1. [Administration of surfactant in hyaline membrane disease].
    Valls i Soler A.
    An Esp Pediatr; 1987 Sep; 27(3):147-51. PubMed ID: 3322119
    [No Abstract] [Full Text] [Related]

  • 2. Pulmonary surfactant and its clinical application.
    Jin HZ.
    Chin Med J (Engl); 1991 Mar; 104(3):225-7. PubMed ID: 2065535
    [No Abstract] [Full Text] [Related]

  • 3. Artificial surfactant therapy for hyaline membrane disease.
    Wigglesworth JS.
    Arch Dis Child; 1980 Oct; 55(10):753-4. PubMed ID: 6893647
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A model of the effect of surfactant treatment on gas exchange in hyaline membrane disease.
    Cotton RB.
    Semin Perinatol; 1994 Feb; 18(1):19-22. PubMed ID: 8209282
    [No Abstract] [Full Text] [Related]

  • 8. [The therapeutic use of pulmonary surfactant in neonatal hyaline membrane disease].
    Lozano-González CH, Piña-Ceballos VM, Beyer-Obezo J, Gutiérrez-Martín A, Martínez-Hinojosa B, Flores-Támez ME.
    Bol Med Hosp Infant Mex; 1993 Jul; 50(7):481-91. PubMed ID: 8363747
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G.
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [Abstract] [Full Text] [Related]

  • 11. Neonatal surfactant replacement therapy. Fetus and Newborn Committee, Canadian Paediatric Society.
    CMAJ; 1992 Apr 15; 146(8):1309-12. PubMed ID: 1555161
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan 15; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 14. Unilateral pulmonary interstitial emphysema and treatment with colfosceril palmitate.
    Abrahamson EL, Viswanath M, Kovar IZ, Jawad SA.
    Lancet; 1993 Jun 19; 341(8860):1603. PubMed ID: 8099684
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of hyaline membrane disease by administration of exogenous surfactant].
    Bonte F, Dehan M, de Fontanges A, Lindenbaum A, Perret L, Puisieux F.
    Arch Fr Pediatr; 1985 May 19; 42(5):397-402. PubMed ID: 3907577
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Surfactants in severe hyaline membrane disease.
    Lancet; 1987 May 02; 1(8540):1040-1. PubMed ID: 2883383
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.